Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014

P. Stefanelli, C. Fazio, A. Neri, S. Boros, G. Renna, M. G. Pompa, Fortunato P. D'Ancona, Maria Grazia Caporali, Richard Aschbacher, Anna Maria Barbui, Maria Chironna, Laura Daprai, Anna Di Taranto, Maria Laura Garlaschi, Maria Paola Landini, Paolo Lanzafame, Antonella Mencacci, Lucia Rossi, Iolanda Santino, Christine Spitaler & 2 others Carlo Tascini, Caterina Vocale

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: In Italy, the incidence of Invasive Meningococcal Disease (IMD) was around 0.28 per 100,000 over the last years. Since the risk IMD is usually high among infants aged less than 1 year, we decided to evaluate the trend of IMD cases reported between 2006 and 2014 in this age group. In particular, the study aim was to describe the main characteristics of IMD cases in infants following the introduction of MCC vaccine (2005) and to estimate the number of cases which are potentially preventable through early vaccination. Methods: The National Surveillance System of Bacterial Meningitis was established in 1994 and in 2007 was extended to all invasive bacterial diseases. Clinical data and isolates and/or clinical samples are collected from hospitalized patients throughout the country. IMD cases are reported by clinicians to the local health authorities, and samples are sent to the Reference Laboratory at the Istituto Superiore di Sanità for further characterization and storage at -80 °C. In particular, serogroup identification is obtained by agglutination with commercial antisera or by multiplex PCR. Results: The annual incidence for infants

Original languageEnglish
Pages (from-to)3678-3681
Number of pages4
JournalVaccine
Volume33
Issue number31
DOIs
Publication statusPublished - Jul 17 2015

Fingerprint

Italy
epidemiology
serotypes
Epidemiology
Vaccines
vaccines
incidence
meningitis
agglutination
antiserum
vaccination
sampling
monitoring
Bacterial Meningitides
Multiplex Polymerase Chain Reaction
Incidence
Agglutination
Serogroup
Immune Sera
Vaccination

Keywords

  • IMD
  • Infant
  • Neisseria meningitidis
  • Surveillance
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014. / Stefanelli, P.; Fazio, C.; Neri, A.; Boros, S.; Renna, G.; Pompa, M. G.; D'Ancona, Fortunato P.; Caporali, Maria Grazia; Aschbacher, Richard; Barbui, Anna Maria; Chironna, Maria; Daprai, Laura; Taranto, Anna Di; Garlaschi, Maria Laura; Landini, Maria Paola; Lanzafame, Paolo; Mencacci, Antonella; Rossi, Lucia; Santino, Iolanda; Spitaler, Christine; Tascini, Carlo; Vocale, Caterina.

In: Vaccine, Vol. 33, No. 31, 17.07.2015, p. 3678-3681.

Research output: Contribution to journalArticle

Stefanelli, P, Fazio, C, Neri, A, Boros, S, Renna, G, Pompa, MG, D'Ancona, FP, Caporali, MG, Aschbacher, R, Barbui, AM, Chironna, M, Daprai, L, Taranto, AD, Garlaschi, ML, Landini, MP, Lanzafame, P, Mencacci, A, Rossi, L, Santino, I, Spitaler, C, Tascini, C & Vocale, C 2015, 'Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014', Vaccine, vol. 33, no. 31, pp. 3678-3681. https://doi.org/10.1016/j.vaccine.2015.06.032
Stefanelli, P. ; Fazio, C. ; Neri, A. ; Boros, S. ; Renna, G. ; Pompa, M. G. ; D'Ancona, Fortunato P. ; Caporali, Maria Grazia ; Aschbacher, Richard ; Barbui, Anna Maria ; Chironna, Maria ; Daprai, Laura ; Taranto, Anna Di ; Garlaschi, Maria Laura ; Landini, Maria Paola ; Lanzafame, Paolo ; Mencacci, Antonella ; Rossi, Lucia ; Santino, Iolanda ; Spitaler, Christine ; Tascini, Carlo ; Vocale, Caterina. / Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014. In: Vaccine. 2015 ; Vol. 33, No. 31. pp. 3678-3681.
@article{9e42b214729544188d2deda97a7280e9,
title = "Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014",
abstract = "Background: In Italy, the incidence of Invasive Meningococcal Disease (IMD) was around 0.28 per 100,000 over the last years. Since the risk IMD is usually high among infants aged less than 1 year, we decided to evaluate the trend of IMD cases reported between 2006 and 2014 in this age group. In particular, the study aim was to describe the main characteristics of IMD cases in infants following the introduction of MCC vaccine (2005) and to estimate the number of cases which are potentially preventable through early vaccination. Methods: The National Surveillance System of Bacterial Meningitis was established in 1994 and in 2007 was extended to all invasive bacterial diseases. Clinical data and isolates and/or clinical samples are collected from hospitalized patients throughout the country. IMD cases are reported by clinicians to the local health authorities, and samples are sent to the Reference Laboratory at the Istituto Superiore di Sanit{\`a} for further characterization and storage at -80 °C. In particular, serogroup identification is obtained by agglutination with commercial antisera or by multiplex PCR. Results: The annual incidence for infants",
keywords = "IMD, Infant, Neisseria meningitidis, Surveillance, Vaccine",
author = "P. Stefanelli and C. Fazio and A. Neri and S. Boros and G. Renna and Pompa, {M. G.} and D'Ancona, {Fortunato P.} and Caporali, {Maria Grazia} and Richard Aschbacher and Barbui, {Anna Maria} and Maria Chironna and Laura Daprai and Taranto, {Anna Di} and Garlaschi, {Maria Laura} and Landini, {Maria Paola} and Paolo Lanzafame and Antonella Mencacci and Lucia Rossi and Iolanda Santino and Christine Spitaler and Carlo Tascini and Caterina Vocale",
year = "2015",
month = "7",
day = "17",
doi = "10.1016/j.vaccine.2015.06.032",
language = "English",
volume = "33",
pages = "3678--3681",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "31",

}

TY - JOUR

T1 - Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014

AU - Stefanelli, P.

AU - Fazio, C.

AU - Neri, A.

AU - Boros, S.

AU - Renna, G.

AU - Pompa, M. G.

AU - D'Ancona, Fortunato P.

AU - Caporali, Maria Grazia

AU - Aschbacher, Richard

AU - Barbui, Anna Maria

AU - Chironna, Maria

AU - Daprai, Laura

AU - Taranto, Anna Di

AU - Garlaschi, Maria Laura

AU - Landini, Maria Paola

AU - Lanzafame, Paolo

AU - Mencacci, Antonella

AU - Rossi, Lucia

AU - Santino, Iolanda

AU - Spitaler, Christine

AU - Tascini, Carlo

AU - Vocale, Caterina

PY - 2015/7/17

Y1 - 2015/7/17

N2 - Background: In Italy, the incidence of Invasive Meningococcal Disease (IMD) was around 0.28 per 100,000 over the last years. Since the risk IMD is usually high among infants aged less than 1 year, we decided to evaluate the trend of IMD cases reported between 2006 and 2014 in this age group. In particular, the study aim was to describe the main characteristics of IMD cases in infants following the introduction of MCC vaccine (2005) and to estimate the number of cases which are potentially preventable through early vaccination. Methods: The National Surveillance System of Bacterial Meningitis was established in 1994 and in 2007 was extended to all invasive bacterial diseases. Clinical data and isolates and/or clinical samples are collected from hospitalized patients throughout the country. IMD cases are reported by clinicians to the local health authorities, and samples are sent to the Reference Laboratory at the Istituto Superiore di Sanità for further characterization and storage at -80 °C. In particular, serogroup identification is obtained by agglutination with commercial antisera or by multiplex PCR. Results: The annual incidence for infants

AB - Background: In Italy, the incidence of Invasive Meningococcal Disease (IMD) was around 0.28 per 100,000 over the last years. Since the risk IMD is usually high among infants aged less than 1 year, we decided to evaluate the trend of IMD cases reported between 2006 and 2014 in this age group. In particular, the study aim was to describe the main characteristics of IMD cases in infants following the introduction of MCC vaccine (2005) and to estimate the number of cases which are potentially preventable through early vaccination. Methods: The National Surveillance System of Bacterial Meningitis was established in 1994 and in 2007 was extended to all invasive bacterial diseases. Clinical data and isolates and/or clinical samples are collected from hospitalized patients throughout the country. IMD cases are reported by clinicians to the local health authorities, and samples are sent to the Reference Laboratory at the Istituto Superiore di Sanità for further characterization and storage at -80 °C. In particular, serogroup identification is obtained by agglutination with commercial antisera or by multiplex PCR. Results: The annual incidence for infants

KW - IMD

KW - Infant

KW - Neisseria meningitidis

KW - Surveillance

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84937635781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937635781&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.06.032

DO - 10.1016/j.vaccine.2015.06.032

M3 - Article

VL - 33

SP - 3678

EP - 3681

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 31

ER -